Keck School Faculty

Neha Nanda

Neha Nanda

Clinical Associate Professor of Medicine, Hospital Epidemiologist and Medical Director of Antimicrobial Stewardship at Keck Medicine of USC, Interim Chief of Infectious Diseases
1500 Health Sciences Campus Los Angeles

Waterbury Hospital : In the Spotlight Award for Recognition of Efforts for Ebola Preparedness, 2015

Yale University: Yale Infectious Diseases Collaborative Fund, 2007

Yale University: William Wirt Winchester Research Fund Award for Tuberculosis Research, 2007

Society of Healthcare and Epidemiology of America: Jonathan Freeman Scholarship for Excellence in Healthcare Epidemiology Research, 2007

Clostridioides difficile Toxin B PCR Cycle Threshold as a Predictor of Toxin Testing in Stool Specimens from Hospitalized Adults Antibiotics (Basel). 2022 Apr 26; 11(5). . View in PubMed

Tixagevimab-Cilgavimab: Utilization in the solid organ transplant population Clin Transplant. 2022 06; 36(6):e14661. . View in PubMed

Leveraging implementation science to advance antibiotic stewardship practice and research Infect Control Hosp Epidemiol. 2022 02; 43(2):139-146. . View in PubMed

Predicting clinical outcomes in COVID-19 using radiomics on chest radiographs Br J Radiol. 2021 Oct 01; 94(1126):20210221. . View in PubMed

Frame to Improve the Fit of N95 Filtering Face Mask Respirators J Occup Environ Med. 2021 Jun 01; 63(6):e362-e366. . View in PubMed

The time to offer treatments for COVID-19 Expert Opin Investig Drugs. 2021 May; 30(5):505-518. . View in PubMed

The Importance of Understanding the Stages of COVID-19 in Treatment and Trials AIDS Rev. 2021 02 08; 23(1):40-47. . View in PubMed

Machine learning based predictors for COVID-19 disease severity Sci Rep. 2021 02 25; 11(1):4673. . View in PubMed

A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population J Adolesc Health. 2020 12; 67(6):763-768. . View in PubMed

Clostridium difficile disease in solid organ transplant recipients: a recommended treatment paradigm Curr Opin Organ Transplant. 2020 08; 25(4):357-363. . View in PubMed

GDH and toxin immunoassay for the diagnosis of Clostridioides (Clostridium) difficile infection is not a 'one size fit all' screening test Diagn Microbiol Infect Dis. 2019 Jun; 94(2):109-112. . View in PubMed

Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms Gastroenterology. 2019 05; 156(6):1905-1913. . View in PubMed

What Really Works for Scope Reprocessing? Infect Control Hosp Epidemiol. 2018 07; 39(7):888-890.. View in PubMed

Clostridium difficile infection in solid organ transplant recipients Curr Opin Organ Transplant. 2017 Aug; 22(4):314-319. . View in PubMed

Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians Tumour Biol. 2013 Jun; 34(3):1901-11. . View in PubMed

Novel biomarkers for the diagnosis of urinary tract infection-a systematic review Biomark Insights. 2009 Aug 05; 4:111-21. . View in PubMed

Part VIIMacrolides, azalides, ketolides, lincosamides, and streptogramins. J Okla State Med Assoc. 2007 Mar; 100(3):75-81. . View in PubMed

Antimicrobial symposiumPart VI. Aminoglycosides and polymyxins. J Okla State Med Assoc. 2007 Feb; 100(2):60-4. . View in PubMed

Lung abscess caused by Clostridium ramosum J Okla State Med Assoc. 2006 Apr; 99(4):158-60. . View in PubMed

Trichomoniasis and its treatment Expert Rev Anti Infect Ther. 2006 Feb; 4(1):125-35. . View in PubMed

Dr. Nanda heads Healthcare Epidemiology/Infection Prevention and Antimicrobial Stewardship at Keck Medicine of USC and its affiliated hospitals and clinics. In this capacity, she leads Keck Medicine's preparation and response for emerging infectious disease. In the last year, through the pandemic, she has led protocol and guideline development as it relates to patient and healthcare safety. Her research interests are geared towards infection prevention strategies and emerging pathogens. Her select publications include the impact of a multidisciplinary approach in reducing preventable harm, treatment strategies and diagnostics for C. difficile and biomarkers for appropriate antimicrobial use.
sc ctsi logoPowered by SC CTSI